Trademark: 76603399
Word
ELSALYN
Status Date
Monday, June 23, 2008
Filing Date
Thursday, July 22, 2004
Published for Opposition
Tuesday, September 27, 2005
Abandoned Date
Monday, June 23, 2008
5 Pharmaceutical preparations for use in the treatment of dermatological disorders, autoimmune disorders, neurological disorders, psoriasis, multiple sclerosis, Crohn's Disease, transplant rejection including host-vs-graft or graft-vs-host reaction, and mitochondrial diseases
Color is not claimed as a feature of the mark.
Aug 20, 2008
Abandonment Notice Mailed - No Use Statement Filed
Aug 20, 2008
Abandonment - No Use Statement Filed
Jan 8, 2008
Extension 4 Granted
Dec 11, 2007
Extension 4 Filed
Dec 11, 2007
Teas Extension Received
Aug 30, 2007
Extension 3 Granted
Jun 15, 2007
Extension 3 Filed
Jun 15, 2007
Teas Extension Received
Dec 7, 2006
Extension 2 Granted
Oct 20, 2006
Extension 2 Filed
Oct 20, 2006
Teas Extension Received
May 8, 2006
Extension 1 Granted
Apr 20, 2006
Extension 1 Filed
Apr 20, 2006
Teas Extension Received
Dec 20, 2005
Noa Mailed - Sou Required From Applicant
Sep 27, 2005
Published For Opposition
Sep 7, 2005
Notice Of Publication
Jul 14, 2005
Law Office Publication Review Completed
Jul 8, 2005
Assigned To Lie
Jul 7, 2005
Approved For Pub - Principal Register
Jun 15, 2005
Teas/Email Correspondence Entered
Jun 6, 2005
Correspondence Received In Law Office
Jun 6, 2005
Teas Response To Office Action Received
Mar 9, 2005
Non-Final Action Mailed
Mar 8, 2005
Non-Final Action Written
Feb 24, 2005
Assigned To Examiner
Aug 3, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
